Literature DB >> 19533820

Severe acute cholestatic hepatitis of unknown etiology successfully treated with the Chinese herbal medicine Inchinko-to (TJ-135).

Susumu Ohwada1, Isao Kobayashi, Nobuo Harasawa, Kyoichiro Tsuda, Yosikatsu Inui.   

Abstract

Severe acute hepatitis of unknown etiology is difficult to treat and often progresses to subacute fulminant hepatitis or late-onset hepatic failure. A 45-year-old well-nourished, healthy man had progressive fatigue and his liver function tests showed severe liver dysfunction. The etiology of sever acute cholestatic hepatitis was unknown. The liver function tests normalized gradually, which excluded high persistent total bilirubin after starting on predonine. A liver biopsy showed chronic active hepatitis with mild fibrosis (A2, F1). Oral Inchinko-to, a Chinese herbal medicine, at 7.5 g daily was prescribed. The treatment was effective with no adverse effects. We present a successfully treated case and discuss hepatoprotective and choleretic effects of Inchinko-to.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19533820      PMCID: PMC2699016          DOI: 10.3748/wjg.15.2927

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

Review 1.  Molecular pathogenesis of cholestasis.

Authors:  M Trauner; P J Meier; J L Boyer
Journal:  N Engl J Med       Date:  1998-10-22       Impact factor: 91.245

2.  Genipin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of TNF-alpha production.

Authors:  Satoko Takeuchi; Takashi Goto; Ken-Ichiro Mikami; Kouichi Miura; Shigetoshi Ohshima; Kazuo Yoneyama; Michiko Sato; Tomomi Shibuya; Daisuke Watanabe; Ei Kataoka; Daisuke Segawa; Ayako Endo; Wataru Sato; Ryutaro Yoshino; Sumio Watanabe
Journal:  Hepatol Res       Date:  2005-11-16       Impact factor: 4.288

3.  [Pharmacological studies of Gardeniae fructus. II. Contribution of the constituent crude drugs to choleretic activity of "Inchinko-to" in rats (author's transl)].

Authors:  M Aburada; H Sasaki; M Harada
Journal:  Yakugaku Zasshi       Date:  1976-02       Impact factor: 0.302

4.  Beneficial effect of a traditional herbal medicine (inchin-ko-to) in postoperative biliary atresia patients.

Authors:  H Kobayashi; K Horikoshi; A Yamataka; G J Lane; M Yamamoto; T Miyano
Journal:  Pediatr Surg Int       Date:  2001-07       Impact factor: 1.827

5.  Lethal effect of the anti-Fas antibody in mice.

Authors:  J Ogasawara; R Watanabe-Fukunaga; M Adachi; A Matsuzawa; T Kasugai; Y Kitamura; N Itoh; T Suda; S Nagata
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

6.  Pharmacological studies on iridoid compounds. II. Relationship between structures and choleretic actions of iridoid compound.

Authors:  S Takeda; K Yuasa; T Endo; M Aburada
Journal:  J Pharmacobiodyn       Date:  1980-10

7.  Fulminant hepatitis and late onset hepatic failure in Japan.

Authors:  Kenji Fujiwara; Satoshi Mochida; Atsushi Matsui; Nobuaki Nakayama; Sumiko Nagoshi; Gotaro Toda
Journal:  Hepatol Res       Date:  2008-03-05       Impact factor: 4.288

8.  A case of severe acute hepatitis of unknown etiology treated with the Chinese herbal medicine Inchinko-to.

Authors:  Makoto Arai; Osamu Yokosuka; Kenichi Fukai; Tatsuo Kanda; Hiroshige Kojima; Shigenobu Kawai; Fumio Imazeki; Hiroyuki Hirasawa; Hiromitsu Saisho
Journal:  Hepatol Res       Date:  2004-03       Impact factor: 4.288

9.  The herbal medicine Inchin-ko-to inhibits liver cell apoptosis induced by transforming growth factor beta 1.

Authors:  M Yamamoto; K Ogawa; M Morita; K Fukuda; Y Komatsu
Journal:  Hepatology       Date:  1996-03       Impact factor: 17.425

10.  A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C.

Authors:  S Takano; Y Ito; O Yokosuka; M Ohto; K Uchiumi; K Hirota; M Omata
Journal:  Hepatology       Date:  1994-09       Impact factor: 17.425

View more
  1 in total

Review 1.  Therapeutic mechanism of Yīn-Chén-Hāo decoction in hepatic diseases.

Authors:  Jian-Yuan Li; Hong-Yan Cao; Lin Sun; Run-Fei Sun; Chao Wu; Yan-Qin Bian; Shu Dong; Ping Liu; Ming-Yu Sun
Journal:  World J Gastroenterol       Date:  2017-02-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.